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Abstract
Healthcare costs have been rapidly increasing in the United States and consume a
significant percentage of the Gross Domestic Product (GDP). A percentage of these costs
are attributed to increased incidences of healthcare overpayments to providers. This study
examined the impact of these overpayments by provider type, and the underlying reasons
which resulted in overpayments from the Medicaid perspective. The theoretical
framework used in this study was Ostrom’s institutional analysis and development (IAD)
framework. The study used all available data (N = 682) from New York State Medicaid
Inspector General final audits of providers for Medicaid overpayments. A chi-square test
of association with a Phi and Cramer’s V analysis was used to test for significance.
Results of the study were significant and suggest that there is a relationship between
provider types and Medicaid overpayment amounts, as well as provider types and error
reasons cited for overpayments. Findings indicate a 56.2% prevalence of overpayments in
long-term care facilities and 78.9% of dentists failed to meet meaningful use
requirements, resulting in the most significant error reason for overpayments.
Recommendations for future study include nationwide collection and aggregation of data
for overpayment analysis. The study contributes to positive social change by adding to
limited body of research regarding overpayments and root causes and allowing providers
and healthcare administration professionals to identify and implement best practices for
reducing overpayments and alleviating healthcare economic burdens.
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Section 1: Foundation of the Study and Literature Review
Introduction
The Centers for Medicare and Medicaid Services (CMS, 2019) reported that the
United States (US) spends approximately 17.7% of its gross domestic product (GDP) on
healthcare expenditures. Furthermore, the US ranks second in terms of highest healthcare
spending in the world (World Bank, 2017). Federal government financing represented the
largest portion of all healthcare spending, with 16% of spending attributed to Medicaid
alone (CMS, 2018). However, as more states adopt Medicaid expansion under the
Affordable Care Act (ACA), Medicaid spending per enrollee is projected to increase
significantly (CMS, 2020).
Given projected increases in Medicaid spending, state budgets will be burdened as
40% of state funds must be allocated to financing Medicaid (Medicaid and CHIP
Payment and Access Commission [MACPAC], n.d.). Additionally, MACPAC noted that
Medicaid consumes the second highest proportion of all state budgets. Not only do states
bear the responsibility to finance Medicaid, but each state is charged to investigate and
combat incidences of Medicaid fraud and improper payments through established
Medicaid Recovery Audit Contractor (RAC) programs (CMS, 2016).
Recoveries due to Medicaid RAC audits include improper payments and
overpayments due to potential fraud and other provider billing errors (CMS, 2016). The
US Government Accountability Office (GAO, 2018) said Medicaid’s vulnerability to
overpayments is due to the size of programs. States should target efforts in identifying
predominant root causes of overpayments and concentrate measures in terms of
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promoting provider compliance to minimize opportunities which reduce the integrity of
Medicaid programs and burden the US healthcare system.
This study will have positive social implications by adding to the limited body of
knowledge on the root causes of Medicaid overpayments from the state perspective. It
can allow best practices to be developed so that Medicaid overpayments will be reduced
and funds available to Medicaid beneficiaries may be employed more effectively.
Effective employment of Medicaid funds could also contribute to lowering overall costs
of healthcare within the US.
This section of the study will frame the problem, outline current gaps in the
research, and delineate the purpose, research questions hypotheses, and the nature of the
study. Additional sections include the theoretical framework, a review of current
literature, search strategies employed in finding relevant literature, and definitions of
pertinent terms used in the literature review. Lastly, Section 1 will highlight assumptions,
scope, and delimitations and the overall significance of the study.
Problem Statement
The Office of the Inspector General (OIG, 2018) reported that $1.6 billion of
overpayments identified in Medicaid RAC audits currently remain outstanding.
Overpayments tend to differ by provider type, and among those provider types, different
reasons are cited for overpayments. Prevalent reasons for overpayments identified in
audits are frequently defined using data processing and medical review error codes as
defined by the CMS. It is imperative that primary reasons for these overpayments are
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investigated as well as why overpayments citations are issued by provider type to prevent
erosion of state healthcare financing and availability of funds for Medicaid beneficiaries.
Gaps in Current Research
No empirical research exists regarding whether there are relationships between
providers and Medicaid overpayments. Few researchers have developed frameworks or
models to improve overpayment identification and detect fraud in healthcare claims. The
OIG conducted an audit of Medicaid providers to find the number of overpayments by
type of provider and reasons for overpayment. The New York State Office of the
Comptroller also conducted an audit of Medicaid claims processing which highlighted
where overpayments were discovered in terms of types of overpayment and provider.
However, none of those audits examined relationships or associations between types of
overpayments and providers.
Purpose of the Study
With an anticipated 5.7 % projected increase in Medicaid expenditures (CMS,
2020) and the impact of rising healthcare costs as evidenced by the 17.7% of the GDP
consumed by healthcare costs, an investigation of the key contributors to Medicaid
spending is warranted. CMS (2020) predicts an estimated 724.5 billion dollars in
Medicaid expenditures for 2022, compounding the economic impact of healthcare costs
by consuming more of the US GDP. Medicaid overpayments to providers drive increases
in spending and influence the availability of state funding (Ekin, 2019; Stowell et al.,
2018; Shay, 2016). Therefore, the purpose of this quantitative study is to determine if
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there is any relationship between provider type, reasons cited for overpayments, and
Medicaid overpayment amounts in New York State (NYS).
Research Questions and Hypotheses
RQ1: Based on NYS OIG overpayment audits, is there a statistically significant
relationship between provider type and Medicaid overpayment amounts?
H01: Based on NYS OIG overpayment audits, there is no statistically significant
association between provider type and Medicaid overpayment amounts.
Ha1: Based on NYS OIG overpayment audits, there is a statistically significant
association between provider type and Medicaid overpayment amounts.
RQ2: Based on NYS OIG overpayment audits, is there a statistically significant
association between provider type and error reasons cited for overpayment?
H02: Based on NYS OIG overpayment audits, there is no statistically significant
association between provider type and error reasons cited for overpayment.
Ha2: Based on the NYS OIG overpayment audits, there is a statistically
significant association between provider type and error reasons cited for overpayment.
Theoretical Foundation for the Study
The theoretical foundation for this study was Elinor Ostrom’s institutional and
analysis development (IAD) framework. Faridah et al. (2020) said the IAD framework is
a health policy analysis framework which involves influencing healthcare policies and
outcomes on an operational level. The IAD framework consists of what Ostrom describes
as the action arena, its actors, and their actions (McGinnis, 2016). The action arena
describes the context of where actors, or those who influence outcomes, interact in their
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environment to effect change based on their actions (Yang & Ren, 2020). Actions are
contingent on rules which govern actions within an institution, as well as systemic
processes and constraints, and are influenced by characteristics of the community they
serve (Ostrom, 2011).
McGinnis (2016) said action arenas are composed of operational, collective, and
constitutional choices. Operational choices are actions exhibited by those who have the
authority to do so. Moreover, collective choices represent actions which underscore
adherence to policies that govern decision making in the action arena. Constitutional
choices highlight whether actions indicate conformity in terms of policies involving
collective choices. Given collective, operational, and constitutional choices, one
assumption of the IAD framework is that actors are aware of the actions which result in
compliance with policies that govern the context of providing services within their
institution (McGinnis, 2016).
Polski and Ostrom (1999) said an institution is defined by processes which govern
interactions between one or more people and therefore can be conceptualized by
providers engaged in delivery of services within respective settings. In other words, an
institution is an entity that comprises of rules and policies which dictate how individuals
such as providers work to deliver their services to the populations that they serve in the
environment where they provide their services. For example, State Medicaid Agencies
(SMAs) provide resources for providers to ensure they are educated and compliant in
terms of billing for services (CMS, 2019). Resources such as Medicaid Integrity Manuals
include legislation which govern overpayments and may include strategies for providers
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to minimize the likelihood of overpayments due to errors (CMS, 2018). Moreover,
Medicaid providers are also provided guidance regarding acts such as fraud (CMS, 2018).
Given resources from Medicaid to promote provider compliance, providers are
armed to make appropriate collective, operational, and constitutional choices. However,
provider actions resulting in overpayments may be indicators of nonconformity in terms
of the aforementioned choices (Ikono et al., 2019). Thus, the IAD framework was used to
address provider actions involving billing Medicaid, how these actions influence
Medicaid overpayments and subsequently the Medicaid population, and how those
actions influence frequency of and reasons why overpayments may occur.
Nature of the Study
The study involved using a quantitative correlational approach. I analyzed final
audit reports of Medicaid overpayments from the NYS Office OMIG for all providers
available. The NYS OMIG provides final audit reports indicating amount of
overpayment as identified in provider audits. Reports also cite the type of provider and
provider actions which resulted in overpayment. The independent variable in this study is
the provider type, and the dependent variables are overpayment amounts and types of
errors which may influence overpayment amounts. Both dependent variables are
presumed to be contingent on provider type. Lastly, the nature of this data suggested that
a quantitative approach was most appropriate for data analysis.
I used a cross-tabulation with a chi-square analysis to determine whether a
correlation exists between provider types and NYS Medicaid overpayment amounts. I
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used a cross-tabulation with a chi-square analysis to analyze whether there were any
statistical associations between provider type and error reasons cited for overpayment.
To highlight the problem in this research, I conducted a thorough review of
existing literature on variables within this study.
Literature Search Strategy
To conduct the literature review, I searched and combined the key words
Medicaid overpayments, Medicaid fraud, Medicaid waste and abuse, Medicaid program
integrity, Medicaid improper billing, and Medicaid billing. I also used the following
databases: Google Scholar, ScienceDirect, Business Source Complete, PubMed, Gale
Academic OneFile Select, Academic Search Complete, CINAHL Plus, and Medline with
Full Text to explore articles related to the research questions. Articles selected for review
were peer-reviewed and published between 2017 and 2021. I also used credible
legislative sources involving governing Medicaid. Since there was little to no empirical
research on Medicaid overpayments by provider type, the literature review involves
specific topics and approaches which result in Medicaid overpayments.
Literature Review
Medicaid
Under Title XIX of the Social Security Act of 1965, the Medicaid program was
developed in response to health needs of individuals with low incomes (Piatak, 2015).
Eligibility for Medicaid at the program’s inception was limited to children, low-income
families, the disabled, and the elderly (Burger & Combs, 2020). Moreover, the power to
implement Medicaid and delineate the scope of services under the program was granted
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to each state with a mandate to cover a range of basic healthcare services from a variety
of providers (Piatak, 2015).
Medicaid is both state and federally funded, with federal funds allocated to match
state expenditures for Medicaid services (Biener et al., 2018). Due to Medicaid
expansions under the ACA, individuals who are at or under 138% of the federal poverty
threshold became eligible for Medicaid (Kobayashi et al., 2019). Medicaid is now
considered one of the largest sources of healthcare funding for individuals in the US
(Chernof, 2019).
Providers who accept Medicaid may receive payments directly through fee-for
service arrangements or managed care contracts with health maintenance organizations
(Keast et al., 2016; Zuvekas & Cohen, 2016). Additionally, state Medicaid agencies are
charged with rate setting and payment thresholds for providers (CMS, 2016). However,
with continued expansion to states, technological advancements, and increases in the
production of goods and services, the Medicaid program demands more allocation of
healthcare financial resources to sustain the program (CMS, 2019). Consequently, this
places the program at increased risk for incidences of fraud, waste and abuse (CMS,
2019; Favre et al., 2020).
Medicaid Audits
Medicaid audits are governed under the Deficit Reduction Act (DRA) of 2005
which was enacted with goals to improve the processes by which Medicaid overpayments
were identified and recouped (CMS, 2019). Under the DRA, the Medicaid Integrity
Program (MIP) was developed to address issues which contribute to fraud, waste, and
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abuse of Medicaid funds (CMS, 2019). The terms fraud, waste, and abuse are used
collectively to describe any acts that may result in improper payment and lead to targeted
goals involving reducing overpayments and preserving federal and state funds (Ikono et
al., 2019).
Other legislation involving Medicaid overpayments include the ACA of 2010.
The ACA and recent revisions include provisions for protecting Medicaid funds by
implementing a 60-day rule mandating that providers return overpayments within 60 days
of discovering the overpayment (Goldin, 2017; Recca, 2016).
Several other programs and legislation exist under the Medicaid program to
combat fraud, waste, and abuse, with the False Claims Act (FCA) law being one of the
most notable for identifying fraud. The Improper Payment Act (IPA) of 2002 was also
enacted to provide oversight for improper payments involving federal dollars and under
this legislation, the Payment Error Measurement Rate (PERM) Medicaid program was
created. Most recently, the Payment Integrity Information Act (PIIA) was enacted to
mitigate the prevalence of improper payments.
Since states have oversight of their own Medicaid programs, each is required to
conduct its own activities to minimize provider actions leading to overpayments. States
may collaborate with Medicaid Fraud Control Units (MCFUs) or Unified Program
Integrity Contractors (UPICs) to investigate and/or audit providers for overpayments
(Beard, 2017; CMS, 2019; GAO, 2018). However, State Medicaid Offices (SMAs) are
mandated to perform and report their own activities to govern fraud, waste, and abuse
(CMS, 2019).
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Audits may be initiated via whistleblowers, irregular billing patterns of providers,
or extrapolation or other statistical sampling methods (Vega, 2018; Shay, 2016). If an
overpayment is identified during any audit or investigation, the SMA is required to
initiate efforts to recoup the overpayment and return the federal share.
Overpayments
Under Medicaid, overpayments may occur in a variety of ways with fraud the
most prevalent, and this presents a significant burden on federal and state funding
(Stowell et al., 2018). Fraud occurs when a provider knowingly and intentionally
commits an act that would result in an increased financial benefit (Joudaki et al., 2016).
In some instances, an unintentional act may turn into fraud (Mata, 2016). If a provider
fails to report the overpayment in a timely manner, it could be potentially investigated as
a fraudulent act (Shay, 2016). Incidences of fraud may include upcoding, unbundling,
drug diversion, overtly billing for services not rendered, and treating patients other than
the actual persons who are recipients of Medicaid (CMS, 2016). Fraud can be committed
by any type of provider involved in the provision of healthcare services (Joudaki et al.,
2016).
Identified overpayments may also contribute to errors occurring in data
processing and medical reviews (CMS, 2019). The CMS has developed codes to
represent all data processing and medical review codes respectively. These codes
encompass all errors identified in audits that providers can make which may result in
overpayment and/or identification of fraud such as unbundling and medically
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unnecessary services. Errors include those attributed to provider billing claims for
ineligible beneficiaries (Blasé & Yelowitx, 2019).
The CMS also produces annual Medicaid reports which indicate the number of
errors identified in samples selected for analysis, totaled overpayments, and projected
nationwide overpayments for each error category. A 2015 Medicaid audit report
assessing over 1,000 patient records in over five states indicated that half the records
analyzed lead to overpayments from accounting and billing errors (CMS, 2015). The
CMS also identifies sources of overpayments and prevalence of errors by provider, as
well as reasons for overpayments, but does not address statistical associations between
provider type and rationale for overpayments.
Fraud
In 2018, 1,109 providers and healthcare agencies were convicted of Medicaid
fraud (OIG, 2018). Trends over a 5-year period demonstrate that 73% of all
investigations conducted by MCFUs result in fraud and consequences for providers such
as exclusion from participating in the program (OIG, 2018). Fraud remains a burgeoning
issue in terms of public healthcare funding (van Capelleveen et al., 2016).
Improper Billing Practices
Upcoding. The CMS (2016) said upcoding is one of the most prevalent forms of
Medicaid fraud among providers. Upcoding occurs when providers submit claims using a
code which results in more profitable reimbursement as related to services provided
(Thornton et al., 2015). A nationwide sampling of claims revealed $6,073.35 in improper
payments due to procedure coding errors with a projected overall improper payment for
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this category in the amount of $67.92 million dollars (CMS, 2018). Procedure coding
errors include any claim submission for a procedure that was not billed appropriately by
the provider and may be an indicator of an overpayment and upcoding (CMS, 2019;
Grant-Kels et al., 2016).
Other Improper Billing Practices
According to the CMS (2016), providers may bill for unnecessary services or
services that were not rendered to patients. Knopf (2019) reported that Acadia Healthcare
Company fraudulently received over $8.5 million dollars by billing Medicaid for tests
that were not needed or used. The actions of Acadia Health Company resulted in over
$2.1 being depleted from West Virginia state funds allocated for Medicaid, with the
remainder representing a decrease in federal funding for Medicaid. Moreover, the CMS
(2019) projected a $0.37 million-dollar loss in Medicaid funds to due medically
unnecessary procedure errors committed by providers in 2019.
Providers also engage in a process called unbundling, which results in
overpayments and fraud (Woodworth et al., 2018). Unbundling occurs when providers
bill Medicaid or other insurance for services separately when one payment for the
procedure should be received (Stowell et al., 2018). Unbundling is one of the most
prevalent unnecessary procedures, along with improper coding (Thornton et al., 2015).
Drug Diversion. Drug diversion also represents one of categories the CMS has
identified as a contributor to fraud and consequent overpayments. Drug diversion occurs
when prescriptions are used illegally by those for whom they were intended for, nor for
prescribed reasons (Keast et al., 2015).
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Kickbacks. Kickbacks also lead to considerable strain on both state and federal
Medicaid dollars and are regarded as a type of healthcare fraud (OIG, n.d.). According to
Favre et al. (2020), the federal anti-kickback statute prevents any providers from
engaging in actions such as recommending a service or product to a patient from which
they may benefit financially. The OIG (2020) said Oklahoma City Hospital was fined
$72.3 million dollars for kickbacks involving patient referrals to healthcare organizations
in which they derived financial benefits.
Provider Types
A provider type may be considered any individual or institution involved in the
provision of services to Medicaid beneficiaries (CMS, 2020). Services include primary
care as provided by primary care physicians, emergency and other acute care services
provided in a hospital, dental services, outpatient services, nursing facilities, and care
provided in the home. Many providers belong to managed care organizations (MCOs)
which bear the responsibility of maintaining a pool of varying providers that administer
services to their enrollees who are covered by Medicaid (Bell et al., 2018).
According to the CMS (2019), providers must abide by state regulations to
participate in Medicaid through a screening process. Requirements for entry to participate
may vary from state to state, as states have the power to set their own requirements for
participation. Moreover, providers are required to be fingerprinted and have their site
visited and approved as appropriate for participation by the state. Additionally, existing
providers participating in the Medicaid program are judged to be low or high-risk
dependent on issues such as whether any previous overpayment exceeds $1,500.
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Despite Medicaid expansion, providers have been historically hesitant to
participate in Medicaid due to low reimbursement rates (Spaulding, 2015). As such,
providers operate within financial constraints with Medicaid as the primary payer and
commit acts such as unbundling and upcoding due to increased payer incentives
(Schonberger et al., 2016). Low reimbursement rates also compromise health outcomes,
with providers delivering subpar care to Medicaid beneficiaries (Chalmers & Compton,
2017). Sonchak (2015) said increased reimbursement leads to better outcomes in prenatal
care. Thus, provider overpayments are a direct consequence of seeking higher
reimbursement rates (Fang & Gong, 2017; Shay, 2016)
Definitions
Audit: Sampling process to identify incidences of overpayments in Medicaid
billing claim submissions (Goldin, 2017).
Drug Diversion: The act in which providers illegally prescribe or provide
medication to an individual it was not intended for (Keast et al., 2015).
Improper Billing: Billing Medicaid inappropriately for including unnecessary
services or services not actually rendered (Thornton et al., 2015).
Improper Payment: Any overpayment or underpayment identified in sampling
Medicaid billing claims (CMS, 2020).
Medicaid: Federal and state funded program to provide health insurance for
individuals with low income and children with state eligibility expansions to individuals
at under 138% of the federal poverty threshold (Kobayashi et al., 2019).
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Overpayments: Any payment made to a Medicaid provider in excess that is
attributed to fraud or other billing errors (Shay, 2016).
Payment Error Measurement Rate (PERM): Medicaid program designed to
identify payment errors which lead to overpayments (CMS, 2019).
Provider Type: Any institution or individual involved in the provision of services
to Medicaid beneficiaries (CMS, 2020).
State Medicaid Agency (SMA): State organizations which handle the
administration of Medicaid programs and are responsible for ensuring provider billing
compliance (CMS, 2019).
Unbundling: Deconstructing services to maximize reimbursement for claims that
are paid under a single payment methodology (Stowell et al., 2018).
Unified Program Integrity Contractors (UPICs): Individuals charged with
conducting Medicaid audits and investigations to identify overpayments (CMS, 2019).
Upcoding: Billing for codes which lead to a higher reimbursement but do not
reflect services provided (Thornton et al., 2015).
Assumptions
A major assumption in this study was that NYS OMIG audit reports were a
credible source of the data. This assumption was necessary so that the study accurately
reflects outcomes as observed in data analysis.
Scope and Delimitations
This study involves all existing Medicaid audits for provider overpayments in
NYS from the NYS OMIG. The study only includes final audits where an overpayment
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was identified. Although the CMS provides aggregates nationwide level data on random
samples to identify overpayments and prevalence of provider errors, the study does not
include this data since it does not demonstrate which errors are specific to the type of
provider. As such, only NYS OMIG Medicaid audits were used since they included data
involving all variables as they relate to a specific type of provider.
Significance of the Study and Social Change
As Medicaid is one the largest providers of healthcare funding in the US
(Chernof, 2019), overpayments heighten the economic burden of healthcare provision
and increase the portion of the GDP attributed to the sector (CMS, 2019). Consistent
strains on Medicaid funding also impact beneficiaries’ access to care, which in turn may
lead to adverse effects on the health of those in need. While methods are being
implemented for change, a targeted approach to protecting Medicaid funding may be
warranted). This study will contribute by addressing resources which may be targeted to
prevent overpayments. It could potentially result in policies to support best practices in
Medicaid billing.
Research Gaps
Based on the literature review, empirical research on statistical associations in
terms of overpayments and Medicaid dollars is largely nonexistent. Due to the lack of
existing research indicating relationships among the variables in this study, my intent was
to conduct this research which addresses statistical associations between overpayments
and Medicaid when aiding SMA-concentrated efforts to promote provider compliance
and preserve state Medicaid funding.
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Summary
Section 1 included a literature review related to variables which are pivotal and
provide a foundation for the study. Legislation pertinent to Medicaid billing, audits, and
overpayments were also explored. The problem of Medicaid overpayments was
underscored as it related to the theoretical IAD framework. This study was justified based
on the magnitude of the identified problem. This section also addressed gaps in the
research topic and how this study will contribute. Section 2 includes the methodology
employed for data acquisition and analysis in the study.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this quantitative study is to determine if there is any relationship
between provider type, reasons cited for overpayments, and Medicaid overpayment
amounts. In this section, I outline the research design selected for the study and rationale
for its selection. This section also includes details regarding data sampling and analysis
procedures for variables within the study. Lastly, in this section, I highlight any threats to
the validity of the study and ethical considerations for acquiring and analyzing data.
Research Design and Rationale
For this study, I chose a quantitative cross-sectional research design as it was
most appropriate for determining if any association exists between study variables. The
independent variable in this study was the provider type with the dependent variables
being overpayment amounts and types of errors which influence overpayment amounts.
Both dependent variables are presumed to be contingent on provider type. The
quantitative cross-sectional research design was also suitable for this study because data
were captured at a single point in time. Moreover, a cross-sectional research design is
also useful for finding associations between variables.
Cross-sectional studies have been used widely in healthcare administration to
investigate financial resources and how they are used and/or employed ineffectively. This
cross-sectional study did not present any financial resources constraints, but considerable
time was required to accumulate data since it was not available as a data set. Data were
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downloaded individually with additional time needed to extract information relevant to
variables being studied.
Methodology
Population, Sampling, and Sampling Procedures
The sample population for this study were providers identified in Medicaid audits
conducted by the NYS OMIG. The NYS OMIG conducts annual audits to identify
overpayment amounts by provider type and cites reasons for errors. Sample data is
readily available on the NYS OMIG website, and each audit was downloaded
individually. Once audits were downloaded, data were extracted from audits for each
variable. Using an Excel file, categories were created for each provider type, which
included types of errors cited for overpayment and overpayment amounts. The sample
only included providers who administered healthcare services during the period between
2019 and 2020. Providers were physicians, hospitals, and dentists, and included those
involved in long-term care, home care, nursing, pharmacy, medical equipment,
transportation, and multi-type facilities.
Power Analysis
I used the G*Power analysis calculator to determine the sample size required for
the study. Creswell (2018) recommended using previous studies as a reference for
estimating the size of the correlation; however, since no other research has involved
variables in this study, I used G*Power’s a priori small effect size for generating an
adequate sample which supports a more representative account of the study population.
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The analysis also involved using the common alpha and beta values of 0.05 and .80,
respectively.
A separate power analysis was conducted to test each hypothesis within the study.
To test RQ1 and RQ2, a G*Power a priori cross-tabulation analysis indicated a required
sample size of 1091 (see Table 1). However, the number of cases in the data set (682)
was determined to be less than recommended in the G*Power analysis for a small effect
size.
Table 1
G*Power Cross-Tabulation Analysis for RQ1 and RQ2
Input parameters
Effect Size w
0.10
0.05
𝛼 err prob
Power (1-β err prob) 0.80
Df
53

Output parameters
Noncentrality parameter 𝝀 10.9100000
7.8147279
Critical 𝝌2
Total Sample size
1091
Actual power
0.8002982

Research Questions and Hypotheses
RQ1: Based on NYS OMIG overpayment audits, is there a statistically significant
relationship between provider type and Medicaid overpayment amounts?
H01: Based on NYS OMIG overpayment audits, there is no statistically
significant association between provider type and Medicaid overpayment amounts.
Ha1: Based on NYS OMIG overpayment audits, there is a statistically significant
association between provider type and Medicaid overpayment amounts.
RQ2: Based on NYS OMIG overpayment audits, is there a statistically significant
association between provider type and error reasons cited for overpayment?
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H02: Based on NYS OMIG overpayment audits, there is no statistically
significant association between provider type and error reasons cited for overpayment.
Ha2: Based on the NYS OMIG overpayment audits, there is a statistically
significant association between provider type and error reasons cited for overpayment.
Operationalization
In this section, I describe main variables which were operationalized in the study.
Provider Type
This refers to the nine different types of providers included in the study that are
responsible for providing clinical services to patients.
Overpayment Amounts
This variable refers to an excess dollar figure identified after auditing provider
types.
Reasons Cited for Overpayments
Any provider error resulting in an overpayment as defined by the CMS or
identified in Medicaid audits (CMS, 2020).
Data Analysis Plan
After obtaining Institutional Review Board (IRB) permission to collect data (IRB
approval number 11-16-20-0603359), audits were downloaded from the OIG website and
information was entered into an Excel file. Data were analyzed using Statistical Package
for the Social Sciences (SPSS), with a cross-tabulation analysis for RQ1 and RQ2. For
cross-tabulation, I used a chi-square test for significance and also reported effect size
using Phi and Cramer’s V measures of association.
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Threats to Validity
Threats to External Validity
A threat to validity in this study was availability of secondary data for this study.
NYS OMIG audit data becomes unavailable as more recent data is added to the website.
As such, the timing of data collection may have affected my ability to gain a large sample
size as indicated in G*Power analyses, which could have potentially affected
generalizability of study results. Availability and quantity of new data may minimize this
threat to external validity.
Threats to Internal Validity
A threat to internal validity was that data for providers may change pending an
appeal of the final audit. If a provider appeals an audit, and it is identified that the
overpayment amount was incorrect, or there was a determination made where the
provider is not liable for the overpayment, then this will affect outcomes of the study as
overpayment amounts, providers, and reasons cited for overpayment can no longer be
included in the study. However, the nature of the cross-sectional design can mitigate this
issue, since data were collected and examined at a single point in time.
Ethical Procedures
The names of providers and their identifying information was not disclosed. All
identifying information was removed and providers were classified according to type of
services they provided. The IRB approval number for this study is 11-16-20-0603359.
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Summary
This section described the design and methods involving data collection.
Secondary data from the NYS OMIG audits were collected and filtered in order to
compile information related to the study. Research questions were analyzed using a
cross-tabulation and chi-square test for independence with Phi and Cramer’s V measures
of association. Section 3 includes findings of data analysis.
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Section 3: Presentation of the Results and Findings
The purpose of this study was to determine if there was any relationship between
provider type, reasons cited for overpayments, and Medicaid overpayment amounts in
NYS. The impetus for this study was the vast growth in the amount of Medicaid
overpayments that have been identified and consequential implications on Medicaid
funding and impact on beneficiaries. Elinor Ostrom’s institutional and analysis
development framework served as the theoretical foundation for the study because of its
widespread use as a health policy analysis framework based on its ability to influence
healthcare policies and outcomes on an operational level of health services provision.
Findings from this study may allow relevant stakeholders and Medicaid agencies to
identify root causes of Medicaid overpayments and implement ways to allocate Medicaid
funds more effectively.
For the study, I used cross-tabulation and a chi-square test for independence with
Phi and Cramer’s V measures of association as the main statistical method for data
analysis. This method enabled comparison of means of categorical variables within the
study and identification of whether there was any statistical significance.
To test for statistical significance between providers and overpayment amounts,
providers were separated by respective categories, which included physicians, dentists,
long-term care, hospital, multi-type facilities, home care, nursing, and an all-other
category for any other providers. The dependent variables overpayment amount and error
reasons cited for overpayments were converted to categorical variables by splitting into
high and low levels based on the median. To test for statistical significance between
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providers and reasons cited for overpayments, reasons identified were categorized by
type into the following groups: missing/improper/insufficient documentation, improper
billing and coding reimbursement for ineligible services and/or providers, failure to meet
meaningful use requirements, and ineligible enrollees.
The study was guided by the following research questions and hypotheses:
RQ1: Based on NYS OMIG overpayment audits, is there a statistically significant
relationship between provider type and Medicaid overpayment amounts?
H01: Based on NYS OMIG overpayment audits, there is no statistically
significant association between provider type and Medicaid overpayment amounts.
Ha1: Based on NYS OMIG overpayment audits, there is a statistically significant
association between provider type and Medicaid overpayment amounts.
RQ2: Based on NYS OMIG overpayment audits, is there a statistically significant
association between provider type and error reasons cited for overpayment?
H02: Based on NYS OMIG overpayment audits, there is no statistically
significant association between provider type and error reasons cited for overpayment.
Ha2: Based on NYS OMIG overpayment audits, there is a statistically significant
association between provider type and error reasons cited for overpayment.
Data Collection of the Secondary Data Set
The data collection process for this study involved downloading all available final
audits from the NYS OMIG for the years 2019 and 2020 at the time of collection. Each
audit was examined to determine the type of provider that was being audited, reasons
cited for overpayment, and amount of overpayment identified. Audits in which

26
overpayments were not identified were not used in the study. Data were manually
extracted from audits and consolidated in Microsoft Excel with unique identifiers to
protect the identity of providers. There were no discrepancies in terms of use of
secondary data.
Results
Table 2 indicates the frequency distribution for each provider according to their
overpayment amount percentages. Additionally, Tables 3 to 7 depict frequency
distributions for variables used in the study according to error reasons cited for
overpayments.
Table 2
Frequency Distribution and Chi-Square Results for Overpayment Amount
Low

High

Variables

Categories

N

%

N

%

N

%

Provider

Dentist

76

13.9

0

0.0

76

11.1

Diagnostic and

29

5.3

5

3.6

34

5.0

Home Care

85

15.6

14

10.2

99

14.5

Hospital

54

9.9

7

5.1

61

8.9

Long Term Care

60

11.0

77

56.2

137

20.1

Multi-Type

96

17.6

16

11.7

112

16.4

Physician

112

20.6

2

1.5

114

16.7

Treatment Center
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All Other

33

6.1

16

11.7

49

7.2

χ2(7) = 167.08, p < .001, 𝞿 = 0.50
Table 3
Frequency Distribution and Chi-Square Results for Ineligible Enrollees
Low

High

Variables

Categories

N

%

N

%

N

%

Provider

Dentist

75

12.3

1

1.4

76

11.1

Diagnostic

31

5.1

3

4.3

34

5.0

Home Care

83

13.6

16

22.9

99

14.5

Hospital

52

8.5

9

12.9

61

8.9

Long Term

133

21.7

4

5.7

137

20.1

Multi-Type

95

15.5

17

24.3

112

16.4

Physician

114

18.6

0

0.0

114

16.7

All Other

29

4.7

20

28.6

49

7.2

and
Treatment
Center

Care

χ2(7) = 85.42, p < .001, 𝞿 = 0.35
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Table 4
Frequency Distribution and Chi-Square Results for Ineligible Services and/or Providers
Low

High

Variables

Categories

N

%

N

%

N

%

Provider

Dentist

75

12.1

1

1.7

76

11.1

Diagnostic

33

5.3

1

1.7

34

5.0

Home Care

95

15.3

4

6.7

99

14.5

Hospital

60

9.6

1

1.7

61

8.9

Long Term

136

21.9

1

1.7

137

20.1

Multi-Type

108

17.4

4

6.7

112

16.4

Physician

80

12.9

34

56.7

114

16.7

All Other

35

5.6

14

23.3

49

7.2

and
Treatment
Center

Care

χ2(7) = 115.07, p < .001, 𝞿 = 0.41
Table 5
Frequency Distribution and Chi-Square Results for Improper Billing and Coding
Low
Variables

Categories

N

High
%

N

%

N

%

29
Provider

Dentist

76

21.2

0

0.0

76

11.1

Diagnostic

5

1.4

29

9.0

34

5.0

Home Care

21

5.9

78

24.1

99

14.5

Hospital

18

5.0

43

13.3

61

8.9

Long Term

133

37.2

4

1.2

137

20.1

Multi-Type

24

6.7

88

27.2

112

16.4

Physician

53

14.8

61

18.8

114

16.7

All Other

28

7.8

21

6.5

49

7.2

and
Treatment
Center

Care

χ2(7) = 294.64, p < .001, 𝞿 = 0.66
Table 6
Frequency Distribution and Chi-Square Results for Improper or Insufficient
Documentation
Low

High

Variables

Categories

N

%

N

%

N

%

Provider

Dentist

35

6.1

41

38.3

76

11.1

Diagnostic

29

5.0

5

4.7

34

5.0

and

30
Treatment
Center
Home Care

80

13.9

19

17.8

99

14.5

Hospital

59

10.3

2

1.9

61

8.9

Long Term

135

23.5

2

1.9

137

20.1

Multi-Type

101

17.6

11

10.3

112

16.4

Physician

106

18.4

8

7.5

114

16.7

All Other

30

5.2

19

17.8

49

7.2

Care

χ2(7) = 142.25, p < .001, 𝞿 = 0.46
Table 7
Frequency Distribution and Chi-Square Results for Failure to Meet Meaningful Use
Requirements
Low

High

Variables

Categories

N

%

N

%

N

%

Provider

Dentist

1

0.2

75

78.9

76

11.1

Diagnostic

34

5.8

0

0.0

34

5.0

99

16.9

0

0.0

99

14.5

and
Treatment
Center
Home Care

31
Hospital

61

10.4

0

0.0

61

8.9

Long Term

137

23.3

0

0.0

137

20.1

Multi-Type

112

19.1

0

0.0

112

16.4

Physician

94

16.0

20

21.1

114

16.7

All Other

49

8.3

0

0.0

49

7.2

Care

χ2(7) = 536.21, p < .001, 𝞿 = 0.89
RQ1 - Results
Using the cross-tabulation technique in SPSS, I analyzed the data using the chisquare test of independence and the Phi and Cramer’s V measures of association to report
the effect size and determine whether there was any statistical association between
provider type and Medicaid overpayment amounts. The chi-square analysis determined
that there was a statistically significant association between provider types and Medicaid
overpayment amounts, χ2(7) = 167.08, p < .001 with a large effect size, 𝞿 = 0.50.
Findings also indicate that 56.2% of overpayments stem from Long Term Care Facilities.
Thus, the null hypothesis that there is no statistically significant association between
provider type and Medicaid Overpayments amounts was rejected. The hypothesis that
there is a statistically significant association between provider type and Medicaid
Overpayments amounts was accepted.
RQ2 - Results
Results of the chi-square analysis support Ha2 given the statistically significant
outcome of the test. For all error reasons there was a statistically significant association
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by provider type which is depicted in Table 8. Figure 1 depicts the prevalence of error
reasons cited for overpayments by provider type. Findings indicate that the most common
error reason resulting in an overpayment was a Failure to Meet Meaningful Use
Requirements by Dentist providers. Thus, the null hypothesis that there is no statistically
significant association between provider type and the error reasons cited for overpayment
was rejected. The hypothesis that there is a statistically significant association between
provider type and the error reasons cited for overpayment was accepted.
Table 8
Chi-Square Test of Independence Results with Report of Effect Size by Reason Cited for
Overpayment
Reason Cited for Overpayment

Chi-Square Test of Independence Effect Size
Result with Effect Size

Ineligible Enrollees

χ2(7) = 85.42, p < .001, 𝞿 = 0.35

Medium

Ineligible Services and/or
Providers

χ2(7) = 115.07, p < .001, 𝞿 =

Medium

0.41
Improper Billing and Coding

χ2(7) = 294.64, p < .001, 𝞿 =

Large

0.66
Missing, Improper or
Insufficient Documentation

χ2(7) = 142.25, p < .001, 𝞿 =
0.46

Medium
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Failure to Meet Meaningful
Use Requirements

χ2(7) = 536.21, p < .001, 𝞿 =

Large

0.89
Figure 1
Reasons Cited for Overpayment: Prevalence by Provider Type

Reasons Cited for Overpayment - Prevalence by Provider Type
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Summary
In this section, I used cross-tabulation and a chi-square analysis to determine
whether there was a statistically significant association between the variables in the
study. Phi and Cramer’s V measures of association were used in the analysis and to
determine the effect size. Results of the analysis indicate a statistically significant
association between provider type and overpayments, and provider type and the error
reasons cited for overpayments.
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To support the cross-tabulation, all variables were coded into categorical variables
with values coded for those which were high and low above the median. A frequency
distribution analysis determined that error reasons cited for overpayments which were
high above the median were prevalent among specific provider types. For the ineligible
enrollees category of reasons cited for overpayments, all-other provider types were found
to be prevalent in contributing to the error. The all-other category includes laboratory,
transportation, pharmacy, durable medical equipment, and nursing providers. For the
ineligible services and/or providers’ error reason, physicians were found to be most
prevalent. The improper billing and coding error reason was prevalent in multi-type
facilities. Lastly, the error reasons improper or insufficient documentation and failure to
meet meaningful use requirements were prevalent in dentists only.
Results of the study support the null hypotheses that there is a statistically
significant relationship between provider type and Medicaid overpayment amounts, and
between provider type and the error reasons cited for overpayments. The application to
professional practice and implication for social change based on the results of this study
are discussed in Section 4.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this study was to determine if there is any relationship between
provider type, reasons cited for overpayments, and Medicaid overpayment amounts in
NYS. Previous research on the topic has been limited and focused specifically on
overpayment reasons such as fraud. Other research has focused on overpayments relating
to specific diagnoses and procedures through random and nationwide sampling methods,
as well as cross-sectional studies to examine provider patterns for fraudulent behavior.
While other research has identified reasons relating to overpayments, little to no research
has been conducted to investigate statistical associations between provider type,
overpayments, and reasons cited for the overpayments.
For this study, I obtained secondary data from the NYS OMIG for the years 2019
and 2020. Data were Medicaid audits where an overpayment was identified, and reasons
cited for the overpayment were evident. I performed a cross tabulation in SPSS using Phi
and Cramer’s V measures of association to examine relationships between variables.
Findings indicate significant associations between provider types and overpayment
amounts as well as reasons for overpayment.
In this section, I discuss interpretations of these findings and the impact and
implication on professional and social change.
Interpretation of the Findings
Results of the study include evidence that there are significant associations
between provider types, overpayment amounts, and reasons cited for overpayments.
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Evidence suggests that the nature of the provider can influence the amount of
overpayment identified in audits. Additionally, reasons cited for overpayments appear to
be prevalent among specific providers. There is evidence to suggest that dentists or dental
providers frequently commit errors involving proper documentation and meeting
meaningful use requirements defined by the Health Information Technology for
Economic and Clinical Health (HITECH) Act. Under the HITECH Act, providers are
required to adopt electronic health record (EHR) systems aimed at improving quality of
care (Lite et al., 2020). Failure to develop required EHR systems will result in an
overpayment for noncompliance as identified in Medicaid audits.
Results of the study also suggest that improper billing and coding is frequent
among multi-type facilities. Improper billing and coding occur for multiple reasons as
noted in the literature review and may be accidental or fraud based. Whether accidental
or not, providers are mandated to report any incidences of overpayment in a timely
manner to reduce the likelihood that it may be considered fraudulent.
Additional evidence in the study indicates that physicians are more likely to
receive overpayments for services where they are ineligible to receive payment, or they
are ineligible to receive payments for services rendered. For all other providers, evidence
suggests that services were rendered to enrollees who were not eligible for services
provided.
Limitations of the Study
Limitations for this study include the size of facilities audited for the study. A
larger facility may result in higher incidences of overpayment based on the volume of
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services it provides. Moreover, NYS OMIG audits are conducted on random facilities
throughout the state, which may influence the number of audits available for a given type
of provider. Also, the study was conducted solely in facilities in NYS; however, the size
of the state and range of provider types are generally applicable to the US.
Recommendations
Recommendations for future studies of this nature include aggregating more data
on healthcare facilities as opposed to random audits. The state can develop a repository
which houses identified incidences of overpayment by facility type as opposed to random
audits. This will allow for a more precise identification and analysis of the root causes of
overpayments as well as more effective ways to combat them. It is also recommended
that other states employ similar mechanisms to capture overpayment data and identify
root causes. Another key recommendation is for Medicaid state agencies to aggregate
overpayment data which the CMS can use for data analysis and identification of
overpayments as well as root causes nationwide.
Application to Professional Practice
The results of this study and current state of overpayment in the US suggest an
urgent need for practitioners to analyze their own institutional data and develop best
practices for reducing overpayments. While Medicaid audits are useful in identifying
overpayments and reasons thereof, those in professional practices can employ their own
methods for preventing and rapidly identifying overpayments. Evidence from the study
strongly suggests that promoting compliance in terms of adhering to CMS requirements
for billing is warranted. Whether it is through training or a culture of billing and
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reimbursement vigilance throughout institutions, best practices can and should be
employed by providers and their staff responsible for Medicaid billing.
Implications for Positive Change
With the current economic crisis compounded by the COVID-19 pandemic, there
is a sense of urgency to reduce the economic burden of healthcare. Rising healthcare
costs which consume a significant portion of the GDP along with healthcare
overpayments and overpayment recovery represent substantial costs of healthcare. This
study and other studies of this nature will help to develop knowledge required to mitigate
healthcare economic issues.
This study adds to a slim body of knowledge regarding how providers influence
overpayments and highlighted the imperative for those in the field to exercise measures
to combat overpayments. Addressing overpayments will allow federal dollars to be
apportioned appropriately and minimize the likelihood that beneficiaries of Medicaid will
experience cutbacks or other constraints on their benefits. Moreover, the preservation of
federal dollars in healthcare can allow other resources to be funded.
Conclusion
In this study, I examined the amount and root causes of Medicaid overpayments
as they relate to varying provider types. Results of the study indicate that there are
statistical associations between provider types and overpayment amounts and the reasons
errors occurred. Evidence of the study warrants further investigation into incidences of
overpayment to combat and reduce their impact on funding Medicaid programs and
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ensuring that low-income and other Medicaid beneficiaries can retain their health benefits
and continue to address their health needs.
Healthcare providers and administration can work collaboratively to promote
compliance in terms of billing and reimbursement requirements from CMS and other
relevant agencies. The results of this study can be used to target problem areas and allow
providers to conduct their own investigations of root causes of overpayments so that they
can be addressed within the respective provider institutions. Addressing overpayments
can lead to millions of dollars being preserved and allocated more efficiently for
Medicaid recipients.
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